Gold R - Search Results

1

A newborn with Pierre Robin sequence after preconceptional mitoxantrone exposure of a female with multiple sclerosis.

Hellwig K, Schimrigk S, Chan A, Epplen J, Gold R. Hellwig K, et al. Among authors: gold r. J Neurol Sci. 2011 Aug 15;307(1-2):164-5. doi: 10.1016/j.jns.2011.05.003. Epub 2011 May 20. J Neurol Sci. 2011. PMID: 21601225

2

Symptomatic hyperekplexia in a patient with multiple sclerosis.

Ruprecht K, Warmuth-Metz M, Waespe W, Gold R. Ruprecht K, et al. Among authors: gold r. Neurology. 2002 Feb 12;58(3):503-4. doi: 10.1212/wnl.58.3.503. Neurology. 2002. PMID: 11839869 No abstract available.

3

Association of a null mutation in the CNTF gene with early onset of multiple sclerosis.

Giess R, Mäurer M, Linker R, Gold R, Warmuth-Metz M, Toyka KV, Sendtner M, Rieckmann P. Giess R, et al. Among authors: gold r. Arch Neurol. 2002 Mar;59(3):407-9. doi: 10.1001/archneur.59.3.407. Arch Neurol. 2002. PMID: 11890844

4

Non-invasive functional and biochemical assessment of mitoxantrone cardiotoxicity in patients with multiple sclerosis.

Spindler M, Weilbach F, Beer M, Sandstede J, Köstler H, Strotmann J, Voelker W, Hahn D, Ertl G, Gold R. Spindler M, et al. Among authors: gold r. J Cardiovasc Pharmacol. 2003 Nov;42(5):680-7. doi: 10.1097/00005344-200311000-00015. J Cardiovasc Pharmacol. 2003. PMID: 14576518

5

Lessons from 10 years of interferon beta-1b (Betaferon/Betaseron) treatment.

Bayas A, Gold R. Bayas A, et al. Among authors: gold r. J Neurol. 2003 Dec;250 Suppl 4:IV3-8. doi: 10.1007/s00415-003-1402-8. J Neurol. 2003. PMID: 14712395 Review.

6

Mechanisms of axonal degeneration in EAE--lessons from CNTF and MHC I knockout mice.

Linker RA, Sendtner M, Gold R. Linker RA, et al. Among authors: gold r. J Neurol Sci. 2005 Jun 15;233(1-2):167-72. doi: 10.1016/j.jns.2005.03.021. Epub 2005 Apr 21. J Neurol Sci. 2005. PMID: 15949503 Review.

7

Current issues in immunomodulatory treatment of multiple sclerosis--a practical approach.

Stangel M, Gold R, Gass A, Haas J, Jung S, Elias W, Zettl UK. Stangel M, et al. Among authors: gold r. J Neurol. 2006 Feb;253 Suppl 1:I32-6. doi: 10.1007/s00415-006-1108-9. J Neurol. 2006. PMID: 16477485 No abstract available.

8

Can pathological patterns be used to guide individualized multiple sclerosis therapy?

Chan A, Gold R. Chan A, et al. Among authors: gold r. Nat Clin Pract Neurol. 2006 Feb;2(2):72-3. doi: 10.1038/ncpneuro0120. Nat Clin Pract Neurol. 2006. PMID: 16932526 No abstract available.

9

Expert opinion: guidelines for the use of natalizumab in multiple sclerosis patients previously treated with immunomodulating therapies.

Gold R, Jawad A, Miller DH, Henderson DC, Fassas A, Fierz W, Hartung HP. Gold R, et al. J Neuroimmunol. 2007 Jul;187(1-2):156-8. doi: 10.1016/j.jneuroim.2007.04.006. Epub 2007 May 11. J Neuroimmunol. 2007. PMID: 17499366 Review.

10

22nd ECTRIMS Congress, Madrid, Spain, 27,30 September 2006.

Gold R. Gold R. Int MS J. 2007 Mar;14(1):10-1. Int MS J. 2007. PMID: 17509247 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results